Roopal Thakkar
Förmögenhet: 14 M $ per 2026-06-30
Förmögenhet: 14 M $ per 2026-06-30
Roopal Thakkar is currently Chief Scientific Officer, Executive VP-R&D at AbbVie, Inc. since 2024.
Formerly, Dr. Thakkar was Chief Medical Officer & Senior Vice President at Global Therapeutics, Inc. Education includes an undergraduate degree from the University of Michigan and a doctorate from Wayne State University School of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ABBVIE, INC. 0 % | 2026-03-06 | 55 374 ( 0 % ) | 14 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| ABBVIE INC. | Teknisk/Vetenskaplig/F&U Direktör | 2003-01-01 |
| Företag | Position | Slut |
|---|---|---|
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Global Therapeutics, Inc.
Global Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in advanced medical devices | Commercial Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wayne State University School of Medicine
Wayne State University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån